


Novamind and Wholeness Center partner on a psychedelic therapy protocol for frontline healthcare workers
Group ketamine therapy for healthcare workers with Covid-based stress & trauma led by Dr. Scott Shannon and Dr. Reid Robison
Learn moreGroup ketamine therapy for healthcare workers with Covid-based stress & trauma led by Dr. Scott Shannon and Dr. Reid Robison
Learn moreA new treatment program to relieve suffering and enhance quality of life
Depression is especially common for people with chronic and serious illness and affects between 24% to 70% of individuals receiving palliative care. Many healthcare practitioners struggle to offer relief with traditional medicine and psychotherapy.
Psychedelic Palliative Care by Novamind is a specialized program designed to provide access to psychedelic medicine and support for people with mental and emotional stress associated with chronic or serious illness.
Among the first-of-its-kind, this innovative program combines psychotherapy, psychedelic medicine, mindfulness and group support in a safe and nurturing environment for patients and their families. The program assembles a multidisciplinary team of mental health professionals and palliative care specialists led by Novamind’s Chief Scientific Officer, Dr. Paul Thielking.
Care
Research
Education
Ketamine-assisted psychotherapy, immersive retreats, workshops and integration groups
Upcoming clinical trials for psilocybin and ketamine-assisted psychotherapy
Online educational content for patients, clinicians and the public coming soon
Care
Ketamine-assisted psychotherapy, immersive retreats, workshops and integration groups
Research
Upcoming clinical trials for psilocybin and ketamine-assisted psychotherapy
Education
Online educational content for patients, clinicians and the public coming soon